Myron W. Wentz

Myron W. Wentz appears in our data through filings on Usana Health Sciences Inc shares, published by SEC (Form 4). Over a trading history stretching from 12 February 2007 to 3 September 2025, the count stands at 293 filings.

Both buying and selling appear: 18 purchases worth €4.7M, against 257 sales worth €442.1M. Sales outweigh purchases by €437.4M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 9 option exercises.

Half of the purchases are above €209k and half below. Clusters matter here: 4 out of 4 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Looking at 8 purchases old enough to measure, the stock rose over the following 90 days in 50% of cases; the median change was +2.8%. These figures describe past trades and do not predict future prices.

The newest entry dates from 5 September 2025: a transaction, in Usana Health Sciences Inc. The last insider purchase was made public on 5 June 2018, 3,078 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.